376 related articles for article (PubMed ID: 25212608)
1. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.
Wolk K; Mitsui H; Witte K; Gellrich S; Gulati N; Humme D; Witte E; Gonsior M; Beyer M; Kadin ME; Volk HD; Krueger JG; Sterry W; Sabat R
Clin Cancer Res; 2014 Nov; 20(21):5507-16. PubMed ID: 25212608
[TBL] [Abstract][Full Text] [Related]
2. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
3. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
[TBL] [Abstract][Full Text] [Related]
4. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
5. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
6. IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis.
Wolk K; Witte K; Witte E; Raftery M; Kokolakis G; Philipp S; Schönrich G; Warszawska K; Kirsch S; Prösch S; Sterry W; Volk HD; Sabat R
Sci Transl Med; 2013 Sep; 5(204):204ra129. PubMed ID: 24068736
[TBL] [Abstract][Full Text] [Related]
7. Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.
Oka T; Sugaya M; Takahashi N; Nakajima R; Otobe S; Kabasawa M; Suga H; Miyagaki T; Asano Y; Sato S
Acta Derm Venereol; 2017 Nov; 97(10):1172-1177. PubMed ID: 28597022
[TBL] [Abstract][Full Text] [Related]
8. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
9. The use of immunohistologic analysis in differentiating cutaneous T-cell lymphoma from psoriasis and dermatitis.
Verga M; Braverman IM
Arch Dermatol; 1991 Oct; 127(10):1503-10. PubMed ID: 1929457
[TBL] [Abstract][Full Text] [Related]
10. Suppression of IL-17A-induced CCL20 production by cytokine inducible SH2-containing protein 1 in epidermal keratinocytes.
Tohyama M; Matsumoto A; Tsuda T; Dai X; Shiraishi K; Sayama K
J Dermatol Sci; 2021 Mar; 101(3):202-209. PubMed ID: 33509657
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 immunoreactivity in epidermis of cutaneous T-cell lymphoma patients.
Wismer JM; McKenzie RC; Sauder DN
Lymphokine Cytokine Res; 1994 Feb; 13(1):21-7. PubMed ID: 8186321
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
13. Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis.
Kamijo H; Miyagaki T; Hayashi Y; Akatsuka T; Watanabe-Otobe S; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
J Invest Dermatol; 2020 Mar; 140(3):636-644.e2. PubMed ID: 31465744
[TBL] [Abstract][Full Text] [Related]
14. Thymic Stromal Chemokine TSLP Acts through Th2 Cytokine Production to Induce Cutaneous T-cell Lymphoma.
Takahashi N; Sugaya M; Suga H; Oka T; Kawaguchi M; Miyagaki T; Fujita H; Sato S
Cancer Res; 2016 Nov; 76(21):6241-6252. PubMed ID: 27634769
[TBL] [Abstract][Full Text] [Related]
15. TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.
Guenova E; Watanabe R; Teague JE; Desimone JA; Jiang Y; Dowlatshahi M; Schlapbach C; Schaekel K; Rook AH; Tawa M; Fisher DC; Kupper TS; Clark RA
Clin Cancer Res; 2013 Jul; 19(14):3755-63. PubMed ID: 23785046
[TBL] [Abstract][Full Text] [Related]
16. The role of IL-22 and Th22 cells in human skin diseases.
Fujita H
J Dermatol Sci; 2013 Oct; 72(1):3-8. PubMed ID: 23746568
[TBL] [Abstract][Full Text] [Related]
17. Early-onset pediatric atopic dermatitis is T
Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
19. Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma.
Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Kawaguchi M; Takahashi N; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2014 Aug; 20(16):4339-48. PubMed ID: 24919568
[TBL] [Abstract][Full Text] [Related]
20. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin.
Correa da Rosa J; Malajian D; Shemer A; Rozenblit M; Dhingra N; Czarnowicki T; Khattri S; Ungar B; Finney R; Xu H; Zheng X; Estrada YD; Peng X; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Mar; 135(3):712-20. PubMed ID: 25583101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]